Overexpression of Na+-dependent myo-inositol transporter gene mouse lens led to congenital cataract

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 6, 2000, Pages 1467-1472

  Jiang, Zhirong ^d   Chung, Sookja K ^d   Zhou, Cheng ^a   Cammarata, Patrick R ^b   Chung, Stephen S M ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL; SODIUM ION;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CATARACTOGENESIS; CONGENITAL CATARACT; DISEASE SEVERITY; EMBRYO; GENE OVEREXPRESSION; IN SITU HYBRIDIZATION; LENS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

EID: 0042748904     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ. 1995;73:115-121.
2. Siman CM, Naeser P, Eriksson UJ. Increased lenticular aldose reductase activity and high incidence of congenital cataract in the offspring of diabetic rats. Acta Ophthalmol (Copenh). 1993;71: 629-636.
3. Varma SD, Kinoshita JH. The absence of cataracts in mice with congenital hyperglycemia. Exp Eye Res. 1974;19:577-582.
4. Ao S, Kikuchi C, Ono T, Notsu Y. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract. Invest Ophthalmol Vis Sci. 1991;32:3078-3083.
5. Griffin BW, McNatt LG, Chandler ML, York BM. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats. Metabolism. 1987;36:486-490.
6. Lee AY, Chung SS. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1999;13:23-30.
7. Ao S, Shingu Y, Kikuchi C, et al. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat. Metabolism. 1991;40:77-87.
8. Crabbe MJ, Goode D. Aldose reductase: a window to the treatment of diabetic complications? Prog Retina Eye Res. 1998;17:313-383.
9. Lee AY, Chung SK, Chung SS. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci USA. 1995;92:2780-2784.
10. Yokoyama T, Lin LR, Chakrapani B, Reddy VN. Hypertonic stress increases NaK ATPase, taurine, and myoinositol in human lens and retinal pigment epithelial cultures. Invest Ophthalmol Vis Sci. 1993;34:2512-2517.
11. Zhou C, Agarwal N, Cammarata PR. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells, 2: cloning of a 626 bp cDNA portion of a Na+/myo-inositol cotransporter, an osmotic shock protein. Invest Ophthalmol Vis Sci. 1994;35:1236-1242.
12. Yamauchi A, Miyai A, Shimada S, et al. Localization and rapid regulation of Na+/myo-inositol cotransporter in rat kidney. J Clin Invest. 1995;96:1195-1201.
13. Beyer-Mears A, Diecke FP, Mistry K, Ellison C, Cruz E. Effect of pyruvate on lens myo-inositol transport and polyol formation in diabetic cataract. Pharmacology. 1997;55:78-86.
14. Diecke FP, Beyer-Mears A, Mistry K. Kinetics of myo-inositol transport in rat ocular lens. J Cell Physiol. 1995;162:290-297.
15. Lal S, Szwergold BS, Taylor AH, Randall WC, Kappler F, Brown TR. Production of fructose and fructose-3-phosphate in maturing rat lenses. Invest Ophthalmol Vis Sci. 1995;36:969-973.
16. Estensen RD, Wattenberg LW. Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice. Carcinogenesis. 1993;14: 1975-1977.
17. Zhou C, Cammarata PR. Cloning the bovine Na+/myo-inositol cotransporter gene and characterization of an osmotic responsive promoter. Exp Eye Res. 1997;65:349-363.
18. Sima AA, Dunlap JA, Davidson EP, et al. Supplemental myo-inositol prevents L-fucose-induced diabetic neuropathy. Diabetes. 1997; 46:301-306.
19. Cammarata PR, Zhou C, Chen G. A transgenic model of osmotic cataract, 1: overexpression of bovine Na+/myo-inositol cotransporter in lens fibers. Invest Ophthalmol Vis Sci. 1999;40:1727-1737.
20. Vander-Jagt D, Robinson B, Taylor KK, Hunsaker LA. Aldose reductase from human skeletal and heart muscle: interconvertible forms related by thiol-disulfide exchange. J Biol Chem. 1990;265: 20982-20987.
21. Vander-Jagt D, Hunsaker LA, Robinson B, Stangebye LA, Deck LM. Aldehyde and aldose reductases from human placenta: heterogeneous expression of multiple enzyme forms. J Biol Chem. 1990; 265:10912-10918.
22. Berry GT, Mallee JJ, Kwon HM, et al. The human osmoregulatory Na+/myo inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. Genomics. 1995;25:507-513.
23. Roizen NJ, Mets MB, Blondis TA. Ophthalmic disorders in children with Down's syndrome. Dev Med Child Neurol. 1994;36:594-560.
24. Caputo AR, Wagner RS, Reynolds DR, Guo SQ, Goel AK. Down syndrome: clinical review of ocular features. Clin Pediatr (Phila). 1989;28:355-358.
25. Robb RM, Marchevsky A. Pathology of the lens in Down's syndrome. Arch Ophthalmol. 1978;96:1039-1042.